CIAP1 and the serine protease HTRA2 are involved in a novel p53-dependent apoptosis pathway in mammals

  1. Shengkan Jin1,
  2. Markus Kalkum2,
  3. Michael Overholtzer1,
  4. Archontoula Stoffel1,
  5. Brian T. Chait2, and
  6. Arnold J. Levine1,3
  1. 1Laboratory of Cancer Biology, 2Laboratory of Mass Spectrometry and Gaseous Ion Chemistry, Rockefeller University, New York, New York 10021, USA

Abstract

Recently a Drosophila p53 protein has been identified that mediates apoptosis via a novel pathway involving the activation of theReaper gene and subsequent inhibition of the inhibitors of apoptosis (IAPs). The present study found that CIAP1, a major mammalian homolog of Drosophila IAPs, is irreversibly inhibited (cleaved) during p53-dependent apoptosis and this cleavage is mediated by a serine protease. Serine protease inhibitors that block CIAP1 cleavage inhibit p53-dependent apoptosis. Furthermore, activation of the p53 protein increases the transcription of the HTRA2 gene, which encodes a serine protease that interacts with CIAP1 and potentiates apoptosis. These results demonstrate that the mammalian p53 protein may activate apoptosis through a novel pathway functionally similar to that in Drosophila, which involves HTRA2 and subsequent inhibition of CIAP1 by cleavage.

Keywords

Footnotes

  • 3 Corresponding author.

  • E-MAIL alevine{at}ias.edu; FAX (609) 924-7592.

  • Article published online ahead of print. Article and publication date are at http://www.genesdev.org/cgi/doi/10.1101/gad.1047003.

    • Received October 2, 2002.
    • Accepted December 2, 2002.
| Table of Contents

Life Science Alliance